ZUG, Switzerland -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, ...
from Content Keyword RSS http://ift.tt/1DdhFbO
via IFTTT
from Content Keyword RSS http://ift.tt/1DdhFbO
via IFTTT
No comments:
Post a Comment